Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Publication year range
1.
J Cancer Res Clin Oncol ; 149(10): 7857-7876, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37039902

ABSTRACT

PURPOSE: KLHDC7B is a member of Kelch family, with a Kelch domain in the C-terminal half, which plays a role in various cellular events, such as cytoskeletal arrangement, protein degradation, gene expression. Although there is increasing evidence supporting KLHDC7B's vital role in tumorigenesis, a systematic analysis of KLHDC7B in cancers remains lacking. Therefore, we intended to investigate the prognostic value for KLHDC7B across 33 cancer types and explore its potential immunological function. METHODS: GEO (Gene Expression Omnibus database) and TCGA (The Cancer Genome Atla) database were used to explore the role of KLHDC7B in 33 cancers. TIMER2, GEPIA2 and Kaplan-Meier plotter were utilized to explore the KLHDC7B expression level and prognostic value in different cancers. The pan cancer genetic variation and DNA methylation of KLHDC7B were analyzed by cBioPortal and MEXPRESS. TIMER2 was employed to investigate the correlation between KLHDC7B expression and immune infiltration. The relationship of KLHDC7B expression with TMB (tumor mutational burden) and MSI (microsatellite instability) were evaluated using Spearman correlation analysis. Finally, by GO and KEGG enrichment analysis, the underlying mechanisms of KLHDC7B in tumor pathophysiology were further investigated. RESULTS: KLHDC7B expression level was related to pathological stages, MSI, TMB, immune checkpoint and immune cell infiltration in most cancers. Especially, we found that the KLHDC7B expression was negatively correlated with the immune infiltration of Myeloid derived suppressor cells into TGCT and GBM. Additionally, survival analysis showed that the expression of KLHDC7B was connected with overall survival (OS) in 3 cancers and disease-free survival (DFS) in 5 cancers. Furthermore, the enrichment analysis revealed that the KLHDC7B collecting genes and binding proteins are related to the function of proteins and immune response. CONCLUSION: KLHDC7B demonstrates strong clinical utility as markers of prognostic and immune response in pan-cancer.


Subject(s)
Kelch Repeat , Neoplasms , Humans , Prognosis , Neoplasms/genetics , Neoplasms/therapy , Carcinogenesis , Immunotherapy , Microsatellite Instability
2.
Front Genet ; 13: 912003, 2022.
Article in English | MEDLINE | ID: mdl-35783266

ABSTRACT

Introduction: Epigenetic-targeted therapy has been increasingly applied in the treatment of cancers. Lysine (K)-specific demethylase 6B (KDM6B) is an epigenetic enzyme involved in the coordinated control between cellular intrinsic regulators and the tissue microenvironment whereas the pan-cancer analysis of KDM6B remains unavailable. Methods: The dual role of KDM6B in 33 cancers was investigated based on the GEO (Gene Expression Omnibus) and TCGA (The Cancer Genome Atlas) databases. TIMER2 and GEPIA2 were applied to investigate the KDM6B levels in different subtypes or stages of tumors. Besides, the Human Protein Atlas database allowed us to conduct a pan-cancer study of the KDM6B protein levels. GEPIA2 and Kaplan-Meier plotter were used for the prognosis analysis in different cancers. Characterization of genetic modifications of the KDM6B gene was analyzed by the cBioPortal. DNA methylation levels of different KDM6B probes in different TCGA tumors were analyzed by MEXPRESS. TIMER2 was applied to determine the association of the KDM6B expression and immune infiltration and DNA methyltransferases. Spearman correlation analysis was used to assess the association of the KDM6B expression with TMB (tumor mutation burden) and MSI (microsatellite instability). The KEGG (Kyoto encyclopedia of genes and genomes) pathway analysis and GO (Gene ontology) enrichment analysis were used to further investigate the potential mechanism of KDM6B in tumor pathophysiology. Results: KDM6B was downregulated in 11 cancer types and upregulated across five types. In KIRC (kidney renal clear cell carcinoma) and OV (ovarian serous cystadenocarcinoma), the KDM6B level was significantly associated with the pathological stage. A high level of KDM6B was related to poor OS (overall survival) outcomes for THCA (thyroid carcinoma), while a low level was correlated with poor OS and DFS (disease-free survival) prognosis of KIRC. The KDM6B expression level was associated with TMB, MSI, and immune cell infiltration, particularly cancer-associated fibroblasts, across various cancer types with different correlations. Furthermore, the enrichment analysis revealed the relationship between H3K4 and H3K27 methylation and KDM6B function. Conclusion: Dysregulation of the DNA methyltransferase activity and methylation levels of H3K4 and H3K27 may involve in the dual role of KDM6B in tumorigenesis and development. Our study offered a relatively comprehensive understanding of KDM6B's dual role in cancer development and response to immunotherapy.

3.
Guang Pu Xue Yu Guang Pu Fen Xi ; 26(4): 761-7, 2006 Apr.
Article in Chinese | MEDLINE | ID: mdl-16836157

ABSTRACT

The analyses of compositions of urinary stones can provide significant reference to the treatment and prevention of recurrence of urolithiasis. In the present paper, the application and research progress of composition analyses of various urinary stones such as calcium oxalates, phosphates, uric acid, urates, cystine etc. by means of modern instruments are summarized. These techniques include Raman spectroscopy, thermogravimetry analysis/differential thermal analysis (TGA/DTA), nuclear magnetic resonance (NMR), high-performance liquid chromatography (HPLC), Fourier infrared (FTIR) spectroscopy, etc.


Subject(s)
Urinary Calculi/chemistry , Urolithiasis/metabolism , Calcium Oxalate/analysis , Calcium Oxalate/metabolism , Humans , Magnetic Resonance Spectroscopy , Phosphates/analysis , Phosphates/metabolism , Spectroscopy, Fourier Transform Infrared , Spectrum Analysis, Raman , Thermogravimetry , Uric Acid/analysis , Uric Acid/metabolism , Urinary Calculi/metabolism
4.
Guang Pu Xue Yu Guang Pu Fen Xi ; 24(7): 876-8, 2004 Jul.
Article in Chinese | MEDLINE | ID: mdl-15766096

ABSTRACT

In a Tween 80-(NH4)2S04-xylenol orange liquid-solid extraction system, absorption spectra of complexes of metal ions in extraction phase with xylenol orange as the extractant were investigated. Compared to xylenol orange spectra, the maximum wavelength of complexes of Cu(II), U(VI) and Ce(IV) shifted to the red by 20-30 nm, while that of La (III) did not. With different acidity, quantites of xylenol orange and salt, and surfactant, the efficiencies of Cu(II), La(III), U(VI) and Ce(IV) metal ions were discussed. The results indicated that the complexes of Cu(II) and U(VI) with xylenol orange were almost completely extracted by the Tween-80 phase, that of Ce(IV) was partially extracted, while that of La(III) was not extracted from the aqueous solution of pH 6.0. The extraction separation of La(III) and U(VI) was carried out by controlling the solution acidity.

SELECTION OF CITATIONS
SEARCH DETAIL